SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-020527
Filing Date
2017-10-31
Accepted
2017-10-31 16:13:29
Documents
94
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bmrn-10q_20170930.htm 10-Q 4027228
2 EX-3.2 bmrn-ex32_235.htm EX-3.2 341476
3 EX-10.1 bmrn-ex101_236.htm EX-10.1 24955
4 EX-31.1 bmrn-ex311_6.htm EX-31.1 16438
5 EX-31.2 bmrn-ex312_7.htm EX-31.2 16506
6 EX-32.1 bmrn-ex321_8.htm EX-32.1 5973
  Complete submission text file 0001564590-17-020527.txt   16332281

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT bmrn-20170930.xml EX-101.INS 4750110
8 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20170930.xsd EX-101.SCH 65965
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmrn-20170930_cal.xml EX-101.CAL 74900
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmrn-20170930_def.xml EX-101.DEF 269398
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20170930_lab.xml EX-101.LAB 505072
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20170930_pre.xml EX-101.PRE 436253
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 171165861
SIC: 2834 Pharmaceutical Preparations